Fluorine-18 (18F)-labelled prostate-specific membrane antigen (PSMA) offers several advantages over gallium-68 (68Ga) in terms of costs, yield, transport/distribution, and image resolution.
This trial investigates the new radiotracer 18F-PSMA-11 via a prospective, intraindividual crossover design.